Inflammation and Parkinson's: Martha Carlin's Eye-Opening Research
Episode Overview
Martha Carlin's citizen scientist approach to Parkinson's disease research is driven by personal experience and a business background, leading her to groundbreaking revelations. Exploration of the link between gram-negative bacteria and neuroinflammation provides key insights into potential causes of Parkinson's symptoms. Martha Carlin's research on lipopolysaccharide (LPS) and its role in inflammation sheds light on the potential impact of endotoxins in Parkinson's disease. The clinical trial of the Sugar Shift probiotic in diabetes uncovers potential connections between diabetes and Parkinson's, opening new avenues for research and management. Martha Carlin's holistic and investigative approach presents a compelling case for a multidimensional understanding of Parkinson's disease and its potential treatments.
Martha Carling, you really are amazing in terms of the way that you go about doing research. You've gone on to study the probiotic in a diabetes clinical trial. Can you tell us a bit about that trial?
Imagine if the root of Parkinson's disease could be traced back to something as seemingly simple as inflammation. In this episode of 'Pathways to Parkinson's Relief', host Robert Rogers sits down with Martha Carlin, a self-taught scientist and founder of BioCollective, to discuss her pioneering research. Martha dives into her work with lipopolysaccharide (LPS), a component found in the cell walls of gram-negative bacteria, and its potential role in causing neuroinflammation linked to Parkinson's symptoms.
Her journey from citizen scientist to a leading researcher is nothing short of inspiring. Through her company's microbiome research and recent clinical trials, Martha offers fresh perspectives on how gut health might influence Parkinson's. Whether you're living with Parkinson's, supporting someone who is, or simply curious about innovative medical research, this conversation is packed with insights that could change how we understand and manage this complex disease.